APA (7th ed.) Citation

JF, M., DC, B., T, M., S, S., Y, K., & K, A. (2023). Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis. JAMA dermatology, 159(10), 1119. https://doi.org/10.1001/jamadermatol.2023.2626

Chicago Style (17th ed.) Citation

JF, Merola, Butler DC, Mark T, Schneider S, Kim Y, and Abuabara K. "Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis." JAMA Dermatology 159, no. 10 (2023): 1119. https://doi.org/10.1001/jamadermatol.2023.2626.

MLA (9th ed.) Citation

JF, Merola, et al. "Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis: A Secondary Analysis." JAMA Dermatology, vol. 159, no. 10, 2023, p. 1119, https://doi.org/10.1001/jamadermatol.2023.2626.